| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-07-23 |
4 |
AS |
$21.38 |
$855,200 |
D/D |
(40,000) |
401,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-12 |
4 |
S |
$15.00 |
$746,818 |
D/D |
(49,771) |
496,762 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-04-23 |
4 |
AS |
$19.95 |
$678,300 |
D/D |
(34,000) |
389,633 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$598,409 |
D/D |
(33,211) |
391,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-12 |
4 |
AS |
$17.96 |
$590,884 |
D/D |
(32,900) |
346,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-13 |
4 |
S |
$15.00 |
$513,388 |
D/D |
(33,950) |
462,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-07-26 |
4 |
AS |
$24.25 |
$485,000 |
D/D |
(20,000) |
381,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-03-09 |
4 |
AS |
$14.83 |
$481,411 |
D/D |
(32,462) |
442,276 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Research |
• – – |
2006-05-03 |
4 |
AS |
$15.60 |
$474,886 |
D/D |
(30,000) |
602,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-06 |
4 |
AS |
$17.69 |
$394,487 |
D/D |
(22,300) |
341,990 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-01-09 |
4 |
OE |
$7.41 |
$374,784 |
D/D |
39,647 |
493,662 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-03 |
4 |
AS |
$22.07 |
$333,610 |
D/D |
(15,116) |
366,874 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-07-05 |
4 |
AS |
$20.35 |
$323,565 |
D/D |
(15,900) |
387,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-11 |
4 |
S |
$15.00 |
$244,332 |
D/D |
(16,279) |
546,533 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-05 |
4/A |
AS |
$15.85 |
$239,241 |
D/D |
(15,000) |
602,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-06-08 |
4 |
AS |
$20.36 |
$185,276 |
D/D |
(9,100) |
402,901 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-06-16 |
4 |
AS |
$17.00 |
$178,500 |
D/D |
(10,500) |
536,312 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-10-03 |
4 |
AS |
$28.70 |
$172,716 |
D/D |
(6,000) |
512,312 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-12-10 |
4 |
OE |
$6.88 |
$172,000 |
D/D |
25,000 |
418,125 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-16 |
4 |
AS |
$15.07 |
$167,277 |
D/D |
(11,100) |
330,605 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-18 |
4 |
A |
$15.37 |
$160,617 |
D/D |
10,450 |
475,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-01 |
4 |
AS |
$15.90 |
$159,469 |
D/D |
(10,000) |
562,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-03 |
4/A |
AS |
$15.60 |
$157,029 |
D/D |
(10,000) |
618,412 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-03-21 |
4 |
OE |
$4.91 |
$153,192 |
D/D |
31,200 |
395,092 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-08-01 |
4 |
AS |
$25.30 |
$152,341 |
D/D |
(6,000) |
524,312 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
